Jul 29, 2025 7:00 am EDT Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference
Jul 25, 2025 7:00 am EDT Castle Biosciences’ Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business Journal
Jul 23, 2025 7:00 am EDT FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test
Jul 17, 2025 7:00 am EDT Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture
Jul 14, 2025 7:00 am EDT Castle Biosciences to Release Second Quarter 2025 Financial Results and Host Conference Call on Monday, Aug. 4, 2025
Jun 19, 2025 7:00 am EDT Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 16, 2025 4:30 pm EDT Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases
Jun 11, 2025 7:00 am EDT Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention
Jun 4, 2025 7:00 am EDT Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards®
